Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Capital Employed (2021 - 2026)

GeneDx Holdings has reported Return on Capital Employed over the past 6 years, most recently at 15.44% for Q1 2026.

  • Quarterly Return on Capital Employed fell 1156.0% to 15.44% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 15.44% through Mar 2026, down 1156.0% year-over-year, with the annual reading at 3.61% for FY2025, 277.0% up from the prior year.
  • Return on Capital Employed was 15.44% for Q1 2026 at GeneDx Holdings, down from 3.27% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 2.55% in Q3 2025 and troughed at 160.04% in Q1 2023.
  • The 5-year median for Return on Capital Employed is 37.62% (2024), against an average of 54.64%.
  • Year-over-year, Return on Capital Employed soared 25153bps in 2022 and then plummeted -8220bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 129.47% in 2022, then surged by 61bps to 50.28% in 2023, then skyrocketed by 87bps to 6.46% in 2024, then skyrocketed by 49bps to 3.27% in 2025, then plummeted by -372bps to 15.44% in 2026.
  • Per Business Quant, the three most recent readings for WGS's Return on Capital Employed are 15.44% (Q1 2026), 3.27% (Q4 2025), and 2.55% (Q3 2025).